Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TGF-β Signaling and Resistance to Cancer Therapy
Maoduo Zhang, Ying Yi Zhang, Yongze Chen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 125

Showing 1-25 of 125 citing articles:

Targeting TGF-β signal transduction for fibrosis and cancer therapy
Dandan Peng, Minyang Fu, Manni Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 571
A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
Hitesh Kumar, Neha Gupta, Rupshee Jain, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 271-292
Open Access | Times Cited: 59
Modelling the complex nature of the tumor microenvironment: 3D tumor spheroids as an evolving tool
Daniel B. Rodrigues, Rui L. Reis, Rogério P. Pirraco
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 17
Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies
Ashkan Pouyan, Masoud Ghorbanlo, Masoud Eslami, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1–High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial
Byoung Chul Cho, Jong Seok Lee, Yi‐Long Wu, et al.
Journal of Thoracic Oncology (2023) Vol. 18, Iss. 12, pp. 1731-1742
Closed Access | Times Cited: 30
The TGF-β Family in Glioblastoma
Irene Golán‐Cancela, Laia Caja
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1067-1067
Open Access | Times Cited: 13
Current approaches in glioblastoma multiforme immunotherapy
Marjan Aghajani, Nazila Jalilzadeh, Ali Aghebati‐Maleki, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 7, pp. 1584-1612
Closed Access | Times Cited: 13
Natural Products in Preventing Tumor Drug Resistance and Related Signaling Pathways
Chuansheng Yang, Zhikai Mai, Can Liu, et al.
Molecules (2022) Vol. 27, Iss. 11, pp. 3513-3513
Open Access | Times Cited: 29
Decoding the mechanisms of chimeric antigen receptor (CAR) T cell-mediated killing of tumors: insights from granzyme and Fas inhibition
Melisa J. Montalvo, Irfan Bandey, Ali Rezvan, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 8
Breaking Barriers: The Promise and Challenges of Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer
Sawsan Sudqi Said, Wisam Nabeel Ibrahim
Biomedicines (2024) Vol. 12, Iss. 2, pp. 369-369
Open Access | Times Cited: 8
Epigenetic modulation of cytokine expression in gastric cancer: influence on angiogenesis, metastasis and chemoresistance
María Elena Reyes, Victoria Pulgar, Carolina Vivallo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling
Najah Albadari, Yang Xie, Wěi Li
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 6
Luteolin Inhibits Lung Cancer Cell Migration by Negatively Regulating TWIST1 and MMP2 Through Upregulation of miR-106a-5p
Qiang Wang, Mengyuan Chen, Xiaofang Tang
Integrative Cancer Therapies (2024) Vol. 23
Open Access | Times Cited: 6
The Role of TAMs in the Regulation of Tumor Cell Resistance to Chemotherapy
Ryan McWhorter, Benjamin Bonavida
Critical Reviews™ in Oncogenesis (2024) Vol. 29, Iss. 4, pp. 97-125
Closed Access | Times Cited: 6
Cellular and molecular mechanisms of gastrointestinal cancer liver metastases and drug resistance
Daosong Dong, Yu Xue, Jingjing Xu, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101125-101125
Closed Access | Times Cited: 6
Identification of hub genes involved in cisplatin resistance in head and neck cancer
Raushan Kumar Chaudhary, Pukar Khanal, Uday Venkat Mateti, et al.
Journal of Genetic Engineering and Biotechnology (2023) Vol. 21, Iss. 1, pp. 9-9
Open Access | Times Cited: 13
Immortalization of Mesenchymal Stem Cells for Application in Regenerative Medicine and Their Potential Risks of Tumorigenesis
Natsuki Yamaguchi, Eri Horio, Jukito Sonoda, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13562-13562
Open Access | Times Cited: 5
Research progress on the antitumor effects of astragaloside IV
Ruixi Zhou, Tiankang Guo, Junliang Li
European Journal of Pharmacology (2022) Vol. 938, pp. 175449-175449
Closed Access | Times Cited: 19
Molecular mechanisms of microRNA-216a during tumor progression
Amir Abbas Hamidi, Negin Taghehchian, Amir Sadra Zangouei, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12
ADAMTS1 induces epithelial-mesenchymal transition pathway in non-small cell lung cancer by regulating TGF-β
Xueqian Hu, Chunqi Jiang, Ning Hu, et al.
Aging (2023) Vol. 15, Iss. 6, pp. 2097-2114
Open Access | Times Cited: 12
Multifaceted TGF‐β signaling, a master regulator: From bench‐to‐bedside, intricacies, and complexities
Sana Ahuja, Sufian Zaheer
Cell Biology International (2023) Vol. 48, Iss. 2, pp. 87-127
Open Access | Times Cited: 11
Identification of 8-(2-methyl phenyl)-9H-benzo[f]indeno[2,1-c]quinolin-9-one (C-5635020) as a Novel and Selective TGFβ RII Kinase Inhibitor for Breast Cancer Therapy
Mesfer Al Shahrani, Mohammad Abohassan, Mohammad Y. Alshahrani, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 746, pp. 151225-151225
Closed Access
Clinical development complexity of TGF-β inhibition: From fibrosis to cancer immunotherapy
Gabriel Gallo-Oller, María Isabel Guillén-Antonini, Javier Dotor
International review of cell and molecular biology (2025)
Closed Access
Cross-Talk Between Tumor Cells and Stellate Cells Promotes Oncolytic VSV Activity in Intrahepatic Cholangiocarcinoma
Victoria Neumeyer, P. Chavan, Katja Steiger, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 514-514
Open Access
Impact of Cancer-Associated Fibroblasts in the Response to Oral Cancer Treatments
Andrea Barahona-Lopez, Miguel Alonso-Juarranz, Santiago Cabezas-Camarero, et al.
IntechOpen eBooks (2025)
Closed Access
Page 1 - Next Page

Scroll to top